logo
Amcor to present at the Bank of America 2025 Global Agriculture and Materials Conference on February 26, 2025

Amcor to present at the Bank of America 2025 Global Agriculture and Materials Conference on February 26, 2025

Yahoo24-02-2025

­ZURICH, Feb. 24, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX:AMC), a global leader in developing and producing responsible packaging solutions will present at the at the Bank of America 2025 Global Agriculture and Materials Conference on Wednesday February 26, 2025.
Amcor's CEO Peter Konieczny and CFO Michael Casamento are scheduled to participate in a fireside chat at 1.15pm Eastern time. To listen to the presentation via live webcast please click here.
A replay of the presentation will be available after the presentation ends at www.amcor.com/investors under 'presentations'.
For further information please contact:
Damon WrightVice President Investor Relationsdamon.wright@amcor.com
About Amcor Amcor is a global leader in developing and producing responsible packaging solutions across a variety of materials for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect products, differentiate brands, and improve supply chains. The Company offers a range of innovative, differentiating flexible and rigid packaging, specialty cartons, closures and services. The company is focused on making packaging that is increasingly recyclable, reusable, lighter weight and made using an increasing amount of recycled content. In fiscal year 2024, 41,000 Amcor people generated $13.6 billion in annual sales from operations that span 212 locations in 40 countries. NYSE: AMCR; ASX: AMC
www.amcor.com I LinkedIn I YouTube
Important Information for Investors and Shareholders
This communication does not constitute an offer to sell or the solicitation of an offer to buy or exchange any securities or a solicitation of any vote or approval in any jurisdiction. It does not constitute a prospectus or prospectus equivalent document. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
In connection with the proposed transaction between Amcor plc ("Amcor") and Berry Global Group ("Berry"), on January 13, 2025, Amcor filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4, as amended on January 21, 2025, containing a joint proxy statement of Amcor and Berry that also constitutes a prospectus of Amcor. The registration statement was declared effective by the SEC on January 23, 2025 and Amcor and Berry commenced mailing the definitive joint proxy statement/prospectus to their respective shareholders on or about January 23, 2025. INVESTORS AND SECURITY HOLDERS OF AMCOR AND BERRY ARE URGED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of the registration statement and the definitive joint proxy statement/prospectus and other documents filed with the SEC by Amcor or Berry through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Amcor are available free of charge on Amcor's website at amcor.com under the tab "Investors" and under the heading "Financial Information" and subheading "SEC Filings." Copies of the documents filed with the SEC by Berry are available free of charge on Berry's website at berryglobal.com under the tab "Investors" and under the heading "Financials" and subheading "SEC Filings."
Certain Information Regarding Participants
Amcor, Berry, and their respective directors and executive officers may be considered participants in the solicitation of proxies from the shareholders of Amcor and Berry in connection with the proposed transaction. Information about the directors and executive officers of Amcor is set forth in its Annual Report on Form 10-K for the year ended June 30, 2024, which was filed with the SEC on August 16, 2024, its proxy statement for its 2024 annual meeting, which was filed with the SEC on September 24, 2024, and its Current Report on Form 8-K, which was filed with the SEC on January 6, 2025. Information about the directors and executive officers of Berry is set forth in its Annual Report on Form 10-K for the year ended September 28, 2024, which was filed with the SEC on November 26, 2024, and its proxy statement for its 2025 annual meeting, which was filed with the SEC on January 7, 2025. Information about the directors and executive officers of Amcor and Berry and other information regarding the potential participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the definitive joint proxy statement/prospectus filed with the SEC and other relevant materials filed with or to be filed with the SEC regarding the proposed transaction when they become available. To the extent holdings of Amcor's or Berry's securities by its directors or executive officers have changed since the amounts set forth in the definitive joint proxy statement/prospectus, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. You may obtain these documents (when they become available) free of charge through the website maintained by the SEC at http://www.sec.gov and from Amcor's or Berry's website as described above.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains certain statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Some of these forward-looking statements can be identified by words like "anticipate," "approximately," "believe," "continue," "could," "estimate," "expect," "forecast," "intend," "may," "outlook," "plan," "potential," "possible," "predict," "project," "target," "seek," "should," "will," or "would," the negative of these words, other terms of similar meaning or the use of future dates. Such statements, including projections as to the anticipated benefits of the proposed transaction, the impact of the proposed transaction on Amcor's and Berry's business and future financial and operating results and prospects, the amount and timing of synergies from the proposed transaction, the terms and scope of the expected financing in connection with the proposed transaction, the aggregate amount of indebtedness of the combined company following the closing of the proposed transaction and the closing date for the proposed transaction, are based on the current estimates, assumptions and projections of the management of Amcor and Berry, and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond Amcor's and Berry's control. None of Amcor, Berry or any of their respective directors, executive officers, or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results of operations or financial condition of Amcor or Berry. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on Amcor's and Berry's businesses, the proposed transaction and the ability to successfully complete the proposed transaction and realize its expected benefits. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to, the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; the risk that the conditions to the completion of the proposed transaction (including shareholder and regulatory approvals) are not satisfied in a timely manner or at all; the risks arising from the integration of the Amcor and Berry businesses; the risk that the anticipated benefits of the proposed transaction may not be realized when expected or at all; the risk of unexpected costs or expenses resulting from the proposed transaction; the risk of litigation related to the proposed transaction; the risks related to disruption of management's time from ongoing business operations as a result of the proposed transaction; the risk that the proposed transaction may have an adverse effect on the ability of Amcor and Berry to retain key personnel and customers; and those risks discussed in Amcor's and Berry's respective filings with the SEC. Forward looking statements included herein are made only as of the date hereof and neither Amcor nor Berry undertakes any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
View original content:https://www.prnewswire.com/news-releases/amcor-to-present-at-the-bank-of-america-2025-global-agriculture-and-materials-conference-on-february-26-2025-302382879.html
SOURCE Amcor

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

Yahoo

timean hour ago

  • Yahoo

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

Johnson & Johnson (NYSE:JNJ) is one of the best stocks for a retirement stock portfolio. On June 12, UBS global equity strategist Andrew Garthwaite's team pointed to Johnson & Johnson as one of the top cyclical picks, excluding financials, whose performance tends to move with the broader economy. A smiling baby with an array of baby care products in the foreground. The stock has gained over 9% in 2025 and currently offers a dividend yield of around 3.4%. Most analysts rate it as a hold, though LSEG data suggests there's still over 9% potential upside from current levels. Last month, Goldman Sachs raised its price target on Johnson & Johnson (NYSE:JNJ) from $172 to $176 and added the stock to its conviction list. The firm made the following statement in its May report: 'JNJ is a stable, defensive grower with the industry's strongest balance sheet allowing for continued high [return on invested capital] investments in the Innovative Medicines segment to augment revenue growth.' The firm highlighted that JNJ 'has a strong pipeline,' with 'meaningful revenue opportunities' in treatments for conditions such as multiple myeloma, lung cancer, and other serious illnesses. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

If You Invested $10K In Ventas Stock 10 Years Ago, How Much Would You Have Now?
If You Invested $10K In Ventas Stock 10 Years Ago, How Much Would You Have Now?

Yahoo

timean hour ago

  • Yahoo

If You Invested $10K In Ventas Stock 10 Years Ago, How Much Would You Have Now?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Ventas Inc. (NYSE:VTR) is a real estate investment trust, which owns, develops, and manages a diverse portfolio of properties such as senior housing communities, outpatient medical buildings, research centers, hospitals, and healthcare facilities. The company's stock traded at approximately $72.75 per share 10 years ago. If you had invested $10,000, you could have bought roughly 137 shares. Currently, shares trade at $63.45, meaning your investment's value could have declined to $8,738 from stock price depreciation. However, Ventas also paid dividends during these 10 years. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – Ventas' dividend yield is currently 3.06%. Over the last 10 years, it has paid about $25.55 in dividends per share, which means you could have made $3,512 from dividends alone. Summing up $8,738 and $3,512, we end up with the final value of your investment, which is $12,250. This is how much you could have made if you had invested $10,000 in Ventas stock 10 years ago. This means a total return of 22.50%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 241%. Ventas has a consensus rating of "Outperform" and a price target of $60.35 based on the ratings of 28 analysts. The price target implies a nearly 5% potential downside from the current stock price. Trending: Invest Where It Hurts — And Help Millions Heal: On April 30, the company announced its Q1 2025 earnings, posting FFO of $0.84, compared to the consensus estimate of $0.82, and revenues of $1.36 billion, compared to the consensus of $1.32 billion, as reported by Benzinga. "Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio, which powered our first quarter results," said CEO Debra A. Cafaro. The company reaffirmed its full-year 2025 guidance, expecting normalized FFO per share in the range of $3.35 to $3.46. Given the expected downside potential, growth-focused investors may not find Ventas stock attractive. Furthermore, they can benefit from the company's solid dividend yield of 3.06%. Check out this article by Benzinga for three more stocks offering high dividend yields. Read Next: , which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. Maximize saving for your retirement and cut down on taxes: . Image: Shutterstock This article If You Invested $10K In Ventas Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Visa Stock Plunges: Here's Why This Analyst Is Bullish
Visa Stock Plunges: Here's Why This Analyst Is Bullish

Business Insider

timean hour ago

  • Business Insider

Visa Stock Plunges: Here's Why This Analyst Is Bullish

Visa (NYSE:V) was amongst several payment processor stocks taking a hit in Friday's trading as crypto's ongoing march toward mainstream adoption has sparked concerns about the implications for the group. Confident Investing Starts Here: Specifically, the Wall Street Journal reported that major retailers are seriously looking into using stablecoins as a way to sidestep the high fees tied to traditional card payments. Companies like Walmart and Amazon have apparently explored creating their own U.S.-based stablecoins, a shift that could potentially save them billions in processing costs by moving away from the conventional banking and card network infrastructure. If either Walmart or Amazon were to launch such a payment system, it could pose a major threat to traditional financial institutions, especially regional and community banks. These retailers not only have enormous customer and employee bases, but also access to massive amounts of consumer data and far fewer regulatory hurdles than banks. That combination has long made them powerful, and potentially disruptive, players in the financial space. Stablecoins are digital tokens typically pegged one-to-one with a government-issued currency like the dollar. They're backed by reserves such as cash or U.S. Treasurys and are currently used mainly for storing value or trading other cryptocurrencies. Whether these retail-led stablecoin projects move forward will likely depend on the outcome of the Genius Act, a bill that would lay the groundwork for stablecoin regulation in the U.S. The legislation recently passed a key procedural step but still needs to clear both the Senate and the House. So, credit card use might get switched to crypto, marking a continuation of sorts as Visa's growth has long been powered by people switching from cash to cards, historically accounting for about two-thirds of its volume growth. For Mizuho's Dan Dolev, an analyst who covers both crypto and payment platforms, a big issue he recently mulled revolved around how much 'US cash conversion runway' remains. Dolev's deep dive into different spending categories suggests that Visa's slower-than-expected growth compared to overall U.S. consumer spending since the pandemic isn't necessarily a sign of weakness. Instead, it's mainly because Americans have been spending more in areas that don't typically rely on cards, like rent or healthcare, and less in card-heavy areas like travel or dining. The good news is this trend is beginning to reverse. More importantly, Dolev believes there's still a lot of untapped potential for card adoption in the U.S. While consensus estimates put card penetration at 80 to 90%, the analyst thinks the real figure is closer to 75%. 'This leaves room for another decade of solid top-line growth domestically. Plus, V's performance in Canada & Nordics offers evidence of above-PCE growth, even when card penetration is >90%,' Dolev said. But whether stablecoin adoption changes all that remains to be seen. All told, for now, Dolev rates V shares as Outperform (i.e., Buy), while his $425 price target makes room for 12-month returns of 20%. (To watch Dolev's track record, click here) The rest of the analyst community remains firmly in V's corner too; the stock claims a Strong Buy consensus rating, based on a mix of 24 Buys and 4 Holds. The average price target stands at $388.85, implying shares will climb 10.5% higher in the months ahead. (See Visa stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store